Lessons Learned From Limited Overlap of 15 In Vitro COVID-19 Drug Repurposing Screens

Drug repurposing can quickly and cost-effectively identify medical countermeasures against pathogens with pandemic potential and could be used as a down-selection method for selecting US Food and Drug Administration-approved drugs to test in clinical trials. We compared results from 15 high-throughp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomezsko, Phillip J., Phillipson, Cassandra W., Walsh, Matthew E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Special Feature: Global Catastrophic Biological Risks
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357111/
https://www.ncbi.nlm.nih.gov/pubmed/37196212
http://dx.doi.org/10.1089/hs.2022.0132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357111/
https://www.ncbi.nlm.nih.gov/pubmed/37196212
http://dx.doi.org/10.1089/hs.2022.0132

Ejemplares similares